We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current KTRA market cap is 419.63M. The company's latest EPS is USD -0.4069 and P/E is -6.39.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.02M | -2.09M | -2.39M | -2.21M | -7.02M |
| Net Income | -1.03M | -2.01M | -2.33M | -2.18M | -6.67M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -38.17M | -22.68M | -14.8M | -8.45M | -17.65M |
| Net Income | -41.5M | -22.66M | -15.02M | -8.5M | -22.65M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.89M | 7.45M | 6.2M | 4.14M | 14.64M |
| Total Liabilities | 2.05M | 1.52M | 2.45M | 2.45M | 4.78M |
| Total Equity | -164k | 5.92M | 3.76M | 1.7M | 9.86M |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.54M | 15.95M | 3.98M | 6.2M | 19.97M |
| Total Liabilities | 2.96M | 4.15M | 3.25M | 2.45M | 5.37M |
| Total Equity | 10.58M | 11.8M | 731k | 3.76M | 14.59M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.43M | -5.73M | -7.18M | -1.89M | -4.74M |
| Investing | -20k | -20k | -20k | N/A | -1.15M |
| Financing | 2.58M | 10.57M | 10.57M | N/A | -548k |
| Year End December 30 2024 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.86M | -20.39M | -11.87M | -7.18M | -14.73M |
| Investing | 964k | N/A | -232k | -20k | -6.05M |
| Financing | 26.04M | 21.64M | 1.85M | 10.57M | 29.77M |
| Market Cap | 419.63M |
| Price to Earnings Ratio | -6.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.43 |
| Price to Book Ratio | 9.92 |
| Dividend Yield | - |
| Shares Outstanding | 55.66M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0.05%) |
| Company Name | Kintara Therapeutics Inc |
| Address |
50 west liberty street reno, nevada 89501 |
| Website | https://www.kintara.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
